Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193805-24-000960
Filing Date
2024-07-24
Accepted
2024-07-24 16:10:21
Documents
1
Period of Report
2024-07-22

Document Format Files

Seq Description Document Type Size
1 e663798_3-skerjanec.html 3  
1 e663798_3-skerjanec.xml 3 1586
  Complete submission text file 0001193805-24-000960.txt   3166
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVIDITY BIOSCIENCES, INC. 10578 SCIENCE CENTER DRIVE, SUITE 125 SAN DIEGO CA 92121
Business Address
Skerjanec Simona (Reporting) CIK: 0002022163 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36201 | Film No.: 241138183